Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

Increase in NF-kappaB binding affinity of the variant C allele of the toll-like receptor 9 -1237T/C polymorphism is associated with Helicobacter pylori-induced gastric disease.

Ng MT, Van't Hof R, Crockett JC, Hope ME, Berry S, Thomson J, McLean MH, McColl KE, El-Omar EM, Hold GL.

Infect Immun. 2010 Mar;78(3):1345-52. doi: 10.1128/IAI.01226-09. Epub 2009 Dec 28.

2.

Polymorphisms in TLR9 but not in TLR5 increase the risk for duodenal ulcer and alter cytokine expression in the gastric mucosa.

Trejo-de la O A, Torres J, Sánchez-Zauco N, Pérez-Rodríguez M, Camorlinga-Ponce M, Flores-Luna L, Lazcano-Ponce E, Maldonado-Bernal C.

Innate Immun. 2015 Oct;21(7):706-13. doi: 10.1177/1753425915587130. Epub 2015 May 20.

PMID:
25995217
3.

TLR9 and NF-κB are partially involved in activation of human neutrophils by Helicobacter pylori and its purified DNA.

Alvarez-Arellano L, Cortés-Reynosa P, Sánchez-Zauco N, Salazar E, Torres J, Maldonado-Bernal C.

PLoS One. 2014 Jul 2;9(7):e101342. doi: 10.1371/journal.pone.0101342. eCollection 2014.

4.

Induction of cyclooxygenase-2 overexpression in human gastric epithelial cells by Helicobacter pylori involves TLR2/TLR9 and c-Src-dependent nuclear factor-kappaB activation.

Chang YJ, Wu MS, Lin JT, Sheu BS, Muta T, Inoue H, Chen CC.

Mol Pharmacol. 2004 Dec;66(6):1465-77. Epub 2004 Sep 29.

PMID:
15456896
5.

Toll-like receptor 9 signaling has anti-inflammatory effects on the early phase of Helicobacter pylori-induced gastritis.

Otani K, Tanigawa T, Watanabe T, Nadatani Y, Sogawa M, Yamagami H, Shiba M, Watanabe K, Tominaga K, Fujiwara Y, Arakawa T.

Biochem Biophys Res Commun. 2012 Sep 28;426(3):342-9. doi: 10.1016/j.bbrc.2012.08.080. Epub 2012 Aug 24.

PMID:
22940550
6.

TLR9 polymorphisms determine murine lymphocyte responses to Helicobacter: results from a genome-wide scan.

Anderson AE, Worku ML, Khamri W, Bamford KB, Walker MM, Thursz MR.

Eur J Immunol. 2007 Jun;37(6):1548-61.

7.

CD14-159C/T and TLR9-1237T/C polymorphisms are not associated with gastric cancer risk in Caucasian populations.

Hold GL, Rabkin CS, Gammon MD, Berry SH, Smith MG, Lissowska J, Risch HA, Chow WH, Mowat NA, Vaughan TL, El-Omar EM.

Eur J Cancer Prev. 2009 Apr;18(2):117-9. doi: 10.1097/CEJ.0b013e3283101292.

8.

Genetic variants of TLR4 and TLR9 are risk factors for chronic Helicobacter pylori infection in South Indian Tamils.

Loganathan R, Nazeer M, Goda V, Devaraju P, Ali M, Karunakaran P, Jayaraman M.

Hum Immunol. 2017 Feb;78(2):216-220. doi: 10.1016/j.humimm.2016.12.002. Epub 2016 Dec 16.

PMID:
27993530
9.

Let-7b is involved in the inflammation and immune responses associated with Helicobacter pylori infection by targeting Toll-like receptor 4.

Teng GG, Wang WH, Dai Y, Wang SJ, Chu YX, Li J.

PLoS One. 2013;8(2):e56709. doi: 10.1371/journal.pone.0056709. Epub 2013 Feb 20.

10.

Helicobacter pylori induces CCL20 expression.

Tomimori K, Uema E, Teruya H, Ishikawa C, Okudaira T, Senba M, Yamamoto K, Matsuyama T, Kinjo F, Fujita J, Mori N.

Infect Immun. 2007 Nov;75(11):5223-32. Epub 2007 Aug 27. Retraction in: Infect Immun. 2011 Jan;79(1):545.

11.

Expression and subcellular distribution of toll-like receptors TLR4, TLR5 and TLR9 on the gastric epithelium in Helicobacter pylori infection.

Schmausser B, Andrulis M, Endrich S, Lee SK, Josenhans C, Müller-Hermelink HK, Eck M.

Clin Exp Immunol. 2004 Jun;136(3):521-6.

12.

Roles played by toll-like receptor-9 in corneal endothelial cells after herpes simplex virus type 1 infection.

Takeda S, Miyazaki D, Sasaki S, Yamamoto Y, Terasaka Y, Yakura K, Yamagami S, Ebihara N, Inoue Y.

Invest Ophthalmol Vis Sci. 2011 Aug 24;52(9):6729-36. doi: 10.1167/iovs.11-7805.

PMID:
21778270
13.

Helicobacter pylori-induced H,K-ATPase alpha-subunit gene repression is mediated by NF-kappaB p50 homodimer promoter binding.

Saha A, Hammond CE, Trojanowska M, Smolka AJ.

Am J Physiol Gastrointest Liver Physiol. 2008 Mar;294(3):G795-807. doi: 10.1152/ajpgi.00431.2007. Epub 2008 Jan 17.

14.

Altered Th17 Cytokine Expression in Helicobacter pylori Patients with TLR4 (D299G) Polymorphism.

Bagheri N, Azadegan-Dehkordi F, Rahimian G, Hashemzadeh-Chaleshtori M, Rafieian-Kopaei M, Kheiri S, Gholipour A, Shirzad H.

Immunol Invest. 2016;45(2):161-71. doi: 10.3109/08820139.2015.1122615. Epub 2016 Feb 6.

PMID:
26853914
15.

Toll-like receptor 2: An important immunomodulatory molecule during Helicobacter pylori infection.

Nemati M, Larussa T, Khorramdelazad H, Mahmoodi M, Jafarzadeh A.

Life Sci. 2017 Jun 1;178:17-29. doi: 10.1016/j.lfs.2017.04.006. Epub 2017 Apr 18. Review.

PMID:
28427896
16.

Influence of polymorphisms in the NOD1/CARD4 and NOD2/CARD15 genes on the clinical outcome of Helicobacter pylori infection.

Rosenstiel P, Hellmig S, Hampe J, Ott S, Till A, Fischbach W, Sahly H, Lucius R, Fölsch UR, Philpott D, Schreiber S.

Cell Microbiol. 2006 Jul;8(7):1188-98.

PMID:
16819970
17.

Toll-like receptor (TLR) 2 induced through TLR4 signaling initiated by Helicobacter pylori cooperatively amplifies iNOS induction in gastric epithelial cells.

Uno K, Kato K, Atsumi T, Suzuki T, Yoshitake J, Morita H, Ohara S, Kotake Y, Shimosegawa T, Yoshimura T.

Am J Physiol Gastrointest Liver Physiol. 2007 Nov;293(5):G1004-12. Epub 2007 Sep 13.

18.

TLR9 activation suppresses inflammation in response to Helicobacter pylori infection.

Varga MG, Piazuelo MB, Romero-Gallo J, Delgado AG, Suarez G, Whitaker ME, Krishna US, Patel RV, Skaar EP, Wilson KT, Algood HM, Peek RM Jr.

Am J Physiol Gastrointest Liver Physiol. 2016 Nov 1;311(5):G852-G858. doi: 10.1152/ajpgi.00175.2016. Epub 2016 Oct 6.

19.

Helicobacter pylori initiates a mesenchymal transition through ZEB1 in gastric epithelial cells.

Baud J, Varon C, Chabas S, Chambonnier L, Darfeuille F, Staedel C.

PLoS One. 2013;8(4):e60315. doi: 10.1371/journal.pone.0060315. Epub 2013 Apr 2.

20.

Helicobacter pylori heat-shock protein 60 induces inflammatory responses through the Toll-like receptor-triggered pathway in cultured human gastric epithelial cells.

Takenaka R, Yokota K, Ayada K, Mizuno M, Zhao Y, Fujinami Y, Lin SN, Toyokawa T, Okada H, Shiratori Y, Oguma K.

Microbiology. 2004 Dec;150(Pt 12):3913-22.

PMID:
15583145

Supplemental Content

Support Center